Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,860 | 301 | 97.2% |
| Education | $198.38 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,892 | 44 | $0 (2024) |
| ABBVIE INC. | $1,240 | 69 | $0 (2024) |
| Lundbeck LLC | $593.95 | 60 | $0 (2024) |
| Alkermes, Inc. | $589.45 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $568.90 | 18 | $0 (2024) |
| Allergan, Inc. | $424.72 | 25 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $420.27 | 12 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $305.22 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $174.83 | 10 | $0 (2024) |
| Axsome Therapeutics, Inc. | $151.77 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,215 | 41 | ABBVIE INC. ($325.43) |
| 2023 | $762.12 | 33 | ABBVIE INC. ($377.53) |
| 2022 | $584.76 | 20 | ABBVIE INC. ($304.49) |
| 2021 | $756.73 | 16 | AbbVie Inc. ($232.72) |
| 2020 | $402.73 | 22 | Lundbeck LLC ($157.78) |
| 2019 | $714.56 | 22 | Otsuka America Pharmaceutical, Inc. ($244.13) |
| 2018 | $1,129 | 69 | Otsuka America Pharmaceutical, Inc. ($373.27) |
| 2017 | $1,493 | 84 | Otsuka America Pharmaceutical, Inc. ($401.75) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $30.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $96.08 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.41 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Neuropsychiatry | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 48 | 143 | $15,158 | $6,452 |
| 2022 | 1 | 76 | 166 | $17,596 | $7,600 |
| 2021 | 1 | 112 | 241 | $25,546 | $9,042 |
| 2020 | 2 | 286 | 563 | $54,242 | $18,221 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 71 | $7,526 | $3,522 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 72 | $7,632 | $2,930 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 96 | $10,176 | $5,067 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 29 | 70 | $7,420 | $2,533 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 58 | 123 | $13,038 | $4,883 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 118 | $12,508 | $4,160 | 33.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 159 | 354 | $30,132 | $10,496 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 113 | 195 | $16,830 | $6,231 | 37.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 14 | 14 | $7,280 | $1,494 | 20.5% |
About Dr. Brian Jones, M.D
Dr. Brian Jones, M.D is a Psychiatry healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033174222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Jones, M.D has received a total of $7,058 in payments from pharmaceutical and medical device companies, with $1,215 received in 2024. These payments were reported across 307 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,860).
As a Medicare-enrolled provider, Jones has provided services to 522 Medicare beneficiaries, totaling 1,113 services with total Medicare billing of $41,316. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Florence, KY
- Active Since 04/19/2006
- Last Updated 03/04/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033174222
Products in Payments
- VRAYLAR (Drug) $1,526
- ABILIFY MAINTENA (Drug) $1,167
- REXULTI (Drug) $1,077
- Aristada 441 mg (Drug) $462.49
- INGREZZA (Drug) $305.22
- AUSTEDO (Drug) $277.62
- SPRAVATO (Drug) $210.49
- INVEGA TRINZA (Drug) $204.57
- TRINTELLIX (Drug) $201.93
- INVEGA SUSTENNA (Drug) $153.84
- Auvelity (Drug) $151.77
- NAMZARIC (Drug) $138.96
- Trintellix (Drug) $136.90
- ABILIFY ASIMTUFII (Drug) $127.53
- COBENFY (Drug) $121.41
- BRIXADI (Drug) $113.10
- LYBALVI (Drug) $104.16
- Fanapt (Drug) $79.97
- CAPLYTA (Drug) $48.84
- LATUDA (Drug) $46.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Florence
Veronica Ridpath, D.o, D.O
Psychiatry — Payments: $110,708
Dr. Nikunjkumar Modi, Md, MD
Psychiatry — Payments: $108,246
Piotr Zieba, Md, MD
Psychiatry — Payments: $13,902
David Anakwenze, M.d, M.D
Psychiatry — Payments: $10,307
James Mazgaj, M.d, M.D
Psychiatry — Payments: $5,013
Robert Bauer, M.d, M.D
Psychiatry — Payments: $2,200